⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARGX News
argenx SE American Depositary Shares
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
argenx to Host Myositis R&D Webinar on June 23, 2026
globenewswire.com
ARGX
argenx to Present at Upcoming Investor Conferences
globenewswire.com
ARGX
Vyvgart Hytrulo (Argenx) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ARGX
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
globenewswire.com
ARGX
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
ARGX
argenx to Present at BofA Securities 2026 Health Care Conference
globenewswire.com
ARGX
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
globenewswire.com
ARGX
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
globenewswire.com
ARGX
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
globenewswire.com
ARGX